TheProfitWatch

KZR - Kezar Life Sciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.3 -0.02 (-0.54%) --- --- 0.0 (0.0%) --- 0.04 (0.81%) 0.0 (0.0%) 0.0 (0.0%)

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.27
Diluted EPS:
-2.27
Basic P/E:
-1.8841
Diluted P/E:
-1.8841
RSI(14) 1m:
0.0
VWAP:
4.28
RVol:
0.5343

Events

Period Kind Movement Occurred At
1m Price increase 1m 4.39 +0.05 (+1.27%) Oct 15 15:28

Related News